State LA
Clinical Trials in Louisiana
Recruiting clinical trials with at least one study location in Louisiana. Data updated daily from ClinicalTrials.gov.
Top Conditions in Louisiana
Peripheral Artery Disease (3)Chronic Lymphocytic Leukemia (3)Asthma (2)Hypertension (2)Small Lymphocytic Lymphoma (2)Endometrial Cancer (2)Anatomic Stage II Breast Cancer AJCC v8 (2)RISS Stage I Plasma Cell Myeloma (2)RISS Stage II Plasma Cell Myeloma (2)Idiopathic Short Stature (2)Acute Myeloid Leukemia (2)Obesity (2)
Frequently Asked Questions — Clinical Trials in Louisiana
How many clinical trials are currently recruiting in Louisiana?
ClinicalMetric currently tracks 125 actively recruiting clinical trials with at least one location in Louisiana. The total number of registered studies—including active but not currently enrolling trials—is 125. Trial availability is updated daily from ClinicalTrials.gov, and new studies open enrollment regularly throughout the year.
What types of clinical trials are available in Louisiana?
Louisiana hosts clinical trials across a broad range of medical conditions, including Peripheral Artery Disease, Chronic Lymphocytic Leukemia, Asthma, and many others. Trials range from Phase 1 early-safety studies to Phase 4 post-approval surveillance, as well as observational and behavioral research. Academic medical centers, community hospitals, and specialized research clinics throughout Louisiana serve as trial sites for studies sponsored by NIH, pharmaceutical companies, and independent investigators.
How do I join a clinical trial near me in Louisiana?
To join a clinical trial in Louisiana, browse the recruiting studies listed on this page, review the eligibility criteria for each trial, and contact the study site directly. Your primary care physician or specialist can also refer you to clinical trials relevant to your diagnosis. Many academic medical centers in Louisiana maintain dedicated clinical trials offices that can match you with appropriate studies based on your medical profile and diagnosis.
Recruiting Trials in Louisiana
NCT03533985 N/A
Recruiting
Effect of Music Therapy on Infants With Neonatal Abstinence Syndrome
Condition
NAS
Enrollment
200 pts
Location
United States
Sponsor
Icahn School of Medicine at Mo
NCT04888104 N/A
Recruiting
Prospective, Multicenter, Case-Control Analysis of the VersaTie Posterior Fixati...
Condition
Adult Spinal Deformity
Enrollment
225 pts
Location
United States
Sponsor
International Spine Study Grou
NCT06593522 Phase 2
Recruiting
A Phase 2 Study of Anvumetostat in Participants With MTAP-deleted Advanced NSCLC...
Condition
MTAP-deleted NSCLC
Enrollment
200 pts
Location
United States, Australia, Brazil
Sponsor
Amgen
NCT06064877 Phase 3
Recruiting
A Study of Ficlatuzumab in Combination With Cetuximab in Participants With Recur...
Condition
Metastatic Head-and-neck Squamous-cell Carcinoma
Enrollment
410 pts
Location
United States, Australia, Belgium
Sponsor
AVEO Pharmaceuticals, Inc.
NCT01255748 N/A
Recruiting
Registry Study for Radiation Therapy Outcomes
Condition
Neoplasms
Enrollment
40,000 pts
Location
United States
Sponsor
Proton Collaborative Group
NCT06784193 Phase 1
Recruiting
Phase 1 Study of OP-3136 in Advanced or Metastatic Solid Tumors
Condition
Advanced or Metastatic ER+ HER2- Breast Cancer (mBC)
Enrollment
180 pts
Location
United States, Australia
Sponsor
Olema Pharmaceuticals, Inc.
NCT04852887 Phase 3
Recruiting
De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, O...
Condition
Stage I Breast Cancer
Enrollment
1,670 pts
Location
United States, Canada, Hong Kong
Sponsor
NRG Oncology
NCT07139821 N/A
Recruiting
Dietary Iron Requirements
Condition
Iron Absorption
Enrollment
300 pts
Location
United States
Sponsor
Pennington Biomedical Research
NCT07137598 Phase 2
Recruiting
A Study to Assess the Efficacy and Safety of RO7790121 in Participants With Mode...
Condition
Rheumatoid Arthritis
Enrollment
160 pts
Location
United States, Argentina, Belgium
Sponsor
Hoffmann-La Roche
NCT06813911 Phase 3
Recruiting
Lp(a) Lowering Study of Pelacarsen (TQJ230) With Background Inclisiran in Partic...
Condition
Atherosclerotic Cardiovascular Disease (ASCVD)
Enrollment
340 pts
Location
United States, China, France
Sponsor
Novartis Pharmaceuticals
NCT05504499 N/A
Recruiting
REFINE Study: A Study In a Novel Interspinous Fusion Device In Subjects With Low...
Condition
Lumbar Spinal Stenosis
Enrollment
100 pts
Location
United States
Sponsor
Pacific Research Institute
NCT06216665 N/A
Recruiting
Effect of Pulsatile Hormone Administration on Insulin Action
Condition
Insulin Sensitivity
Enrollment
12 pts
Location
United States
Sponsor
Pennington Biomedical Research
NCT05762107 Phase 2
Recruiting
A Study of the Effect of ZT-01 on Night-time Hypoglycemia in Type 1 Diabetes
Condition
Type 1 Diabetes Mellitus With Hypoglycemia
Enrollment
186 pts
Location
United States, Canada
Sponsor
Zucara Therapeutics Inc.
NCT06465745 N/A
Recruiting
AltaValve Pivotal Trial
Condition
Mitral Regurgitation
Enrollment
450 pts
Location
United States, Germany, Greece
Sponsor
4C Medical Technologies, Inc.
NCT03808922 Phase 3
Recruiting
Phase III DAS181 Lower Tract PIV Infection in Immunocompromised Subjects (Substu...
Condition
Lower Respiratory Tract Infection
Enrollment
274 pts
Location
United States, Australia, China
Sponsor
Ansun Biopharma, Inc.
NCT06419374 Phase 3
Recruiting
A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With...
Condition
Metabolic Dysfunction-Associated Steatohepatitis (MASH) / Nonalcoholic Steatohepatitis (NASH) With Compensated Cirrhosis
Enrollment
762 pts
Location
United States, Argentina, Australia
Sponsor
89bio, Inc.
NCT06269705 Phase 3
Recruiting
ZILRETTA in Subjects With Shoulder Osteoarthritis
Condition
Glenohumeral Osteoarthritis
Enrollment
150 pts
Location
United States
Sponsor
Pacira Pharmaceuticals, Inc
NCT06283966 Phase 3
Recruiting
A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fum...
Condition
COPD (Chronic Obstructive Pulmonary Disease)
Enrollment
5,000 pts
Location
United States, Argentina, Australia
Sponsor
AstraZeneca
NCT06852222 Phase 3
Recruiting
A Study of Bleximenib, Venetoclax and Azacitidine For Treatment of Participants ...
Condition
Leukemia, Myeloid, Acute
Enrollment
600 pts
Location
United States, Australia, Austria
Sponsor
Janssen Research & Development
NCT07009860 Phase 2
Recruiting
RESTORE TRIAL: A Phase 2 Study Evaluating the Efficacy and Safety of Pemvidutide...
Condition
Alcohol Liver Disease
Enrollment
100 pts
Location
United States, Puerto Rico
Sponsor
Altimmune, Inc.
NCT03907046 Phase 3
Recruiting
Anticoagulation in ICH Survivors for Stroke Prevention and Recovery
Condition
Intracerebral Hemorrhage
Enrollment
700 pts
Location
United States
Sponsor
Yale University
NCT06029439 Phase 3
Recruiting
Study to Assess the Safety and Effectiveness of NMRA-335140-501
Condition
Major Depressive Disorder
Enrollment
1,000 pts
Location
United States, Brazil, Bulgaria
Sponsor
Neumora Therapeutics, Inc.
NCT05261139 Phase 3
Recruiting
EPIC-Peds: A Study to Learn About the Study Medicine Called PF-07321332 (Nirmatr...
Condition
COVID-19
Enrollment
160 pts
Location
United States, Bulgaria, Japan
Sponsor
Pfizer
NCT06902519 Phase 1
Recruiting
Study of GS-0151 in Participants With Rheumatoid Arthritis
Condition
Rheumatoid Arthritis
Enrollment
75 pts
Location
United States, Georgia, Germany
Sponsor
Gilead Sciences
NCT06655207 N/A
Recruiting
Pivotal, Prospective, Multi-centre, Single-arm Study to Evaluate the Safety and ...
Condition
Post Partum Haemorrhage
Enrollment
1,000 pts
Location
United States, Australia
Sponsor
Baymatob Operations Pty Ltd
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology